1. Home
  2. BREA vs SILO Comparison

BREA vs SILO Comparison

Compare BREA & SILO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BREA
  • SILO
  • Stock Information
  • Founded
  • BREA 2022
  • SILO 2010
  • Country
  • BREA Ireland
  • SILO United States
  • Employees
  • BREA N/A
  • SILO N/A
  • Industry
  • BREA Services-Misc. Amusement & Recreation
  • SILO Apparel
  • Sector
  • BREA Consumer Discretionary
  • SILO Consumer Discretionary
  • Exchange
  • BREA Nasdaq
  • SILO Nasdaq
  • Market Cap
  • BREA 8.7M
  • SILO 8.8M
  • IPO Year
  • BREA 2023
  • SILO N/A
  • Fundamental
  • Price
  • BREA $0.61
  • SILO $1.59
  • Analyst Decision
  • BREA
  • SILO
  • Analyst Count
  • BREA 0
  • SILO 0
  • Target Price
  • BREA N/A
  • SILO N/A
  • AVG Volume (30 Days)
  • BREA 61.7K
  • SILO 805.4K
  • Earning Date
  • BREA 01-03-2025
  • SILO 02-18-2025
  • Dividend Yield
  • BREA N/A
  • SILO N/A
  • EPS Growth
  • BREA N/A
  • SILO N/A
  • EPS
  • BREA N/A
  • SILO N/A
  • Revenue
  • BREA $2,872,101.00
  • SILO $72,102.00
  • Revenue This Year
  • BREA N/A
  • SILO $1.86
  • Revenue Next Year
  • BREA N/A
  • SILO N/A
  • P/E Ratio
  • BREA N/A
  • SILO N/A
  • Revenue Growth
  • BREA 2338.69
  • SILO N/A
  • 52 Week Low
  • BREA $0.50
  • SILO $0.77
  • 52 Week High
  • BREA $3.00
  • SILO $4.50
  • Technical
  • Relative Strength Index (RSI)
  • BREA 40.15
  • SILO 52.57
  • Support Level
  • BREA $0.62
  • SILO $1.56
  • Resistance Level
  • BREA $0.68
  • SILO $1.89
  • Average True Range (ATR)
  • BREA 0.05
  • SILO 0.19
  • MACD
  • BREA -0.01
  • SILO -0.05
  • Stochastic Oscillator
  • BREA 14.37
  • SILO 27.12

About BREA Brera Holdings PLC

Brera Holdings PLC focused on expanding social impact football by developing a international portfolio of emerging football clubs with increased opportunities to earn tournament prizes, gain sponsorships, and provide other professional football and related consulting services.

About SILO Silo Pharma Inc.

SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.

Share on Social Networks: